In #CancerCare, biosimilar entry for bevacizumab, rituximab, and trastuzumab was associated with lower reference product prices and market share, along with lower payer and patient costs.
@jamaoncology.com
@jamaoncology.comIn #CancerCare, biosimilar entry for bevacizumab, rituximab, and trastuzumab was associated with lower reference product prices and market share, along with lower payer and patient costs.
@med-news.bsky.socialThe 2nd Annual Bras for the Cause, "Together We Can Knock Out Cancer," held earlier this summer at The Peacock Lounge & Grille, raised $61,372 for the Abben Cancer Center of Spencer Hospital.
@moica05.bsky.socialDr. Surender Kumar Dabas: Expert Robotic Cancer Surgeon at BLK-Max Hospital Delhi.
Watch Our Video:- youtube.com/shorts/afdmu...
#DrSurenderDabas #RoboticCancerSurgery #RoboticSurgery #SurgicalOncology #CancerSurgeon #CancerCare #BLKMax #RoboticOncology #DelhiSurgeon
@siogorg.bsky.socialFive days left to register for SIOG 2026 at early bird rates. Closes 8 September. And yes, SIOG members pay the lowest rates.
https://loom.ly/ITKRCJQ
#SIOG2026 #GeriatricOncology #GeriOnc #CancerCare